Data as of Aug 21
| -0.06 / -1.33%|
The 2 analysts offering 12-month price forecasts for Biocept Inc have a median target of 15.00, with a high estimate of 16.00 and a low estimate of 14.00. The median estimate represents a +237.08% increase from the last price of 4.45.
The current consensus among 2 polled investment analysts is to Buy stock in Biocept Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.